Welcome back to a new semester of Dissertation Diaries. As a reminder, this is the series where we highlight Ph.D. students ...

Researchers from Carnegie Mellon University have discovered a way to target RNA that could lead to new treatment options for ...

Scientists at Johns Hopkins have uncovered a surprising new way to influence brain activity by targeting a long-mysterious class of proteins linked to anxiety, schizophrenia, and movement disorders.

One of SeaWorld San Diego’s first rescues of 2026 was in La Jolla following reports of a malnourished fur seal pup in the ...

Researchers from Carnegie Mellon University have discovered a way to target RNA that could lead to new treatment options for myotonic dystrophy type 1 (DM1), the most common adult-onset form of ...

Larimar Therapeutics is deeply undervalued, trading at ~$3.40 despite a de-risked safety profile and a clear regulatory path ...

This month: cuffless BP issues in practice, women and lifetime CVD risk, targeting kids for early education, and more.

Biohaven has suffered a few setbacks in recent months, including an FDA rejection and a missed $150 million benchmark payment ...

DarioHealth Corp. (the "Company", "DarioHealth" or "Dario"), a leader in global digital health, today announced that it has surpassed 100 scientific studies, including peer-reviewed journal ...

Johns Hopkins researchers found that delta-type ionotropic glutamate receptors (GluDs) play a key role in regulating neuronal ...

Kinder Surprise Eggs – The Chocolate Treat America Can’t Have Kinder Surprise Eggs – The Chocolate Treat America Can’t Have ...

CARVYKTI ® is the first and only BCMA-targeted CAR-T cell therapy approved for the treatment of patients with multiple myeloma who have had at least one prior line of therapy. Globally, CARVYKTI ® is ...